Generate a tailored SOP for Dr. Roger Reeves. Improve your application with a focused, well-structured draft.
Dr. Roger Keith Reeves obtained his Ph.D. from the University of Alabama-Birmingham, focusing on dendritic cell biology and lentivirus infections. He completed his postdoctoral training in lentivirus vaccinology and innate immunity at the New England Primate Research Center, Massachusetts General Hospital, and Harvard Medical School. He became faculty at Harvard Medical School, serving as an Associate Professor before joining Duke University in 2021 as a tenured Professor in the Department of Surgery and Department of Pathology. As the Director of the Duke Center for Human Systems Immunology, Dr. Reeves oversees significant research initiatives, supported by NIH for 15 years, including multiple R grants and participation in consortia such as the HIV Vaccine Trials Network. He is a recognized expert in natural killer cell biology and has published over 100 research papers. His current research focuses on harnessing NK cells in the context of vaccines and immunotherapeutics for various viruses including HIV, CMV, and SARS-CoV-2. Additionally, he serves as an Editor-in-Chief for the journal AIDS Research and Human Retroviruses and has mentored numerous trainees throughout his career.
Duke University • Durham, NC
Director of the Duke Center for Human Systems Immunology, overseeing research initiatives.
Harvard Medical School •
Faculty member focusing on immunology and virology.
Department of Biomedical Engineering (MS program)